Q1 2016 · 10-Q
Revenue$29.00M$29.00M +8.5% vs Q1 2015−5.6% vs Q4 2015
Net Income-$19.88M-$19.88M N/M vs Q1 2015N/M vs Q4 2015
EPS Diluted-$0.69-$0.69 N/M vs Q1 2015N/M vs Q4 2015
Operating Income-$18,869,000N/M
Operating Cash Flow-$7,792,000N/M
Free Cash Flowderived-$8,936,000N/M
Margins · derived
Operating margin-65.1%−12.7 pt vs Q1 2015
Net margin-68.6%−9.0 pt vs Q1 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $29.00M | $26.73M | $25.72M | $14.54M |
| Net Income | -$19.88M | -$15.93M | -$15.41M | -$3.55M |
| EPS Diluted | -$0.69 | -$0.56 | -$0.57 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR